Αρχική World News Can I Have a Non-Violent Relationship with Cancer (Part 2)

Can I Have a Non-Violent Relationship with Cancer (Part 2)

This is part 2 of Marisa’s blog. To read part 1, click here.

Treating Cancer Without a Violent Spirit

Having established that cancer is not my enemy can I find a less antagonistic way to face cancer? A cancer diagnosis is a grave problem, for sure, a scary reality evoking a wide range of feelings that I must manage. If at all possible, it would be better for me – for a peaceful day, an appreciative life – if I could avoid harboring negative emotions like anger, hatred, contempt, anxiety, or even disrespect towards this disease. The alternatives are not fatalism or passivity. I know that awareness and action are required: at a minimum, an awareness of my body’s disease situation, and a willingness to proactively support the processes that lead to cancer suppression and restoration of health.

There is no question that treating a cancer unleashes intense life-death biochemical conflict within the body, as the defective cells are found and eliminated. Surgery, radiation, chemotherapy are all harsh forms of killing or removing cancer cells, and they often damage other healthy cells as collateral damage. The body is shocked and stressed and traumatized by many of these treatments. I personally am benefiting from newer approaches like immunotherapies that are somewhat less punishing, but the treatment regimen I’m on is still a major intervention in the life of the body. For incurable cancers like my own, a lifetime rhythm of treatment-remission-relapse-treatment cycles has to be expected and embraced. If I am lucky, the right treatments might yield a treasured time of regained health, even though it will be temporary in the big picture.

The hard work of suppressing or eliminating the cancer cells is worth real effort; it is the pathway to restoring health. In this strenuous and challenging dynamic, I personally don’t want to think of myself as a warrior, or as someone in a battle. That makes “me” – my conscious mind – an enemy commander against my own body. It makes inevitable the sense of a split, a taking of sides, a good side, and an evil side. But I am all of me – the things in me that work and the ones that don’t. While incurable cancer is truly a serious disease, it is not true that I am being personally hunted down. There are parts of me, like the mutated myeloma cells, that don’t contribute to the common good anymore, so they have to be found and removed. I have no problem with that approach. It is the use of scientific power, but without animosity or anger – an active but nonviolent response to the threat to my life.

I don’t hate the myeloma cells. I do fervently hope to banish this cancer for a good long time, but I don’t want to live from a stance of being a violent adversary to my own self or to others. I want to walk this cancer journey in peace with myself as a whole person, who appreciates the gift of a body, even its flaws, and weakness, and off-course parts. This desire is very important to me, a core of my spirituality and my view of life.

Yes, I’ll Do My Best to Stay Peaceful

Despite enormous strides in treatment, my cancer is not known to be curable. As far as we know, the myeloma will continue to mutate, and it will eventually arrive at a type for which there is no effective treatment. Someday – if I’m lucky, that “someday” will be years hence – I will be faced with a cancer that can no longer be controlled unless I die of something else first.

What this means to me is that the nonviolent attitude with which I would like to live with my cancer must also become the nonviolent attitude with which to befriend the reality of my eventual death. I am guessing that the gift of serenity in the face of mortality might be rare. My father had it. I hope I will, too.

In the meantime, I will stay the course here, doing my best to act diligently in cooperation with the treatment process. Instead of envisioning myself standing at the gates of my body-castle with lances bristling, I imagine myself setting up a safe, comfortable healing room within its walls. That is the place where the myeloma is being found and dismantled, the “m-spikes” are drawn down, the “light chains” disappear. (That’s Multiple Myeloma lingo.)

Instead of a stance of cold and armored rejection of anything to do with cancer, I hope to be able to maintain a posture of support, containment, and protection for my body as it metabolizes the chemo drugs and suppresses the cancer. I will do my best to encourage my body, cooperate with it, and I will wait as it works on my behalf. Not so much a warrior, but rather a faithful companion to my compromised body.

These are my reflections at a very early stage of a permanent new-normal for me; I can’t say what I will feel or think later. I hope I can retain a sense of openness, gratitude, and patience towards what life brings me, without being taken over too often with the unavoidable feelings of fear, grief, or anger. I am trying to assertively confront the problem that cancer represents as I go through treatment, while I do my best to navigate my cancer journey from a nonviolent and peaceful spirit. I don’t have any illusions that this will be easy, and I know it isn’t the path for everyone… but it does seem to be right for me.

Marisa Guerin, PhD, is retired from a career that spanned three phases: first, as Director of the national office for national Catholic youth ministry; second, as Vice President of Human Resources for a major international manufacturing company; and third, as President of her own consulting company, providing support to businesses and nonprofit organizations on issues related to management, strategy, and leadership. Marisa holds a doctorate in Human and Organizational Systems and served for five years on the Project Faculty of the Wharton Global Consulting Practicum. A native of the Philadelphia area, Marisa lives in West Philadelphia with her husband, Mike Sweeney. Marisa was diagnosed in August 2021 with Multiple Myeloma.



Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like

Διαβαστε Επίσης

Καρκίνος και Κορωνοϊός (COVID-19) ΜΕΡΟΣ Α

Εάν είστε καρκινοπαθής, το ανοσοποιητικό σας σύστημα μπορεί να μην είναι τόσο ισχυρό όσο κανονικά, έτσι μπορεί να ανησυχείτε για τους κινδύνους που σχετίζονται...


Η Παγκόσμια Ημέρα Κατά του Καρκίνου καθιερώθηκε με πρωτοβουλία της Διεθνούς Ένωσης κατά του Καρκίνου (UICC), που εκπροσωπεί 800 οργανώσεις σε 155 χώρες του...


ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...
- Advertisment -

Ροή Ειδήσεων

Breast Cancer Survivor Invents Warming Bra Insert to Combat Cold Feeling of Breast Implants

In 2013, Kristen Carbone, of Providence, Rhode Island, had a preventative mastectomy to help protect herself against breast cancer after her mother died of...

FDA Approves Daratumumab plus Hyaluronidase-fihj, Carfilzomib, and Dexamethasone for Relapsed or Refractory Multiple Myeloma

On 30 November 2021, the US Food and Drug Administration (FDA) approved daratumumab plus hyaluronidase-fihj (Darzalex Faspro, Janssen Biotech, Inc.) and carfilzomib (Kyprolis, Amgen,...

Thanks For Making This GivingTuesday Our Best One Yet!

We set ambitious goals for GivingTuesday, but they were driven by a time of great need. With your help, we hoped to provide food and...

Over 600 people in England set to benefit from innovative lung cancer treatment

<img width="620" height="348" src="https://34p2k13bwwzx12bgy13rwq8p-wpengine.netdna-ssl.com/wp-content/uploads/2021/05/lung_cell_cropped-hero.jpg" class="attachment-featuredImage size-featuredImage" alt="Lung cancer cell" loading="lazy" srcset="https://34p2k13bwwzx12bgy13rwq8p-wpengine.netdna-ssl.com/wp-content/uploads/2021/05/lung_cell_cropped-hero.jpg 620w, https://34p2k13bwwzx12bgy13rwq8p-wpengine.netdna-ssl.com/wp-content/uploads/2021/05/lung_cell_cropped-hero-300x168.jpg 300w, https://34p2k13bwwzx12bgy13rwq8p-wpengine.netdna-ssl.com/wp-content/uploads/2021/05/lung_cell_cropped-hero-220x123.jpg 220w, https://34p2k13bwwzx12bgy13rwq8p-wpengine.netdna-ssl.com/wp-content/uploads/2021/05/lung_cell_cropped-hero-150x84.jpg 150w" sizes="(max-width: 620px) 100vw, 620px" data-attachment-id="18781" data-permalink="https://news.cancerresearchuk.org/2020/09/11/targeted-drug-for-lung-cancer-approved-for-nhs-use-in-england/lung_cell_cropped-hero/"...

Touching a nerve: How neuroscience could advance our understanding of cancer

KTSDESIGN/SCIENCE PHOTO LIBRARY When supporters donate to our work, their combined generosity might lead to a new discovery that inches us closer to, for example,...

Nivolumab Demonstrates Clinical Benefits in a Statistically Evaluable Number of Patients with CUP

An investigator-initiated phase II study is the first to show that nivolumab has clinical activity with manageable toxicity in a statistically evaluable number of...